Skip to content

Clinical Observation on Tongdu Tiaoshen Acupuncture Combined with Zengye Roujin Decoction for Post-stroke Muscular Hypertonia with Yin deficiency pneumatic

Clinical Observation on Tongdu Tiaoshen Acupuncture Combined with Zengye Roujin Decoction for Post-stroke Muscular Hypertonia with Yin deficiency pneumatic

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300069626
Enrollment
Unknown
Registered
2023-03-22
Start date
2023-04-01
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

post-stroke muscular hypertonia

Interventions

control group:Basic treatment of stroke combined with Tongdu Tiaoshen acupuncture
observation group:Basic treatment of stroke combined withTongdu Tiaoshen Acupuncture Zengye Roujin Decoction

Sponsors

The Second Affiliated Hospital of Anhui University of Traditinonal Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria of Chinese and Western medicine for stroke, and the diagnostic criteria ofYin deficiency pneumatic syndromes; 2. In the non-acute attack period, the patient's condition is in a stable period, and the disease duration is = grade I); 5. No sedatives or muscle relaxants have been taken in the past 2 weeks; 6. The patient volunteered to participate and signed the informed consent form.

Exclusion criteria

Exclusion criteria: 1. In acute phase; 2. Increased muscle tone due to other reasons; 3. Complicated with severe functional diseases, such as severe heart failure and coronary heart disease; 4. Those who are mentally and emotionally abnormal and unable to cooperate with treatment; 5. Those who receive treatment other than this study protocol; 6. People who are afraid of needles or faint of needles, blood coagulation disorders, allergic constitution or allergic to multiple drugs; 7. Those who did not complete the whole course of treatment according to the doctor's instructions or the required data were incomplete, which affected the efficacy or safety judgment.

Design outcomes

Primary

MeasureTime frame
Fugl-Meyer assessment, FMA;RMS value of EMG;

Secondary

MeasureTime frame
National Institutes of Health Stroke Scale;

Countries

China

Contacts

Public ContactHan Wei

The Second Affiliated Hospital of Anhui University of Traditinonal Chinese Medicine

13956060099@139.com+86 13955199550

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026